Macrophage Targeting Transforms Fibrosis Therapy, Wyss Institute Secures 12M Fetal Monitoring Deal, Global Secondhand Smoke Exposes Millions, Cortical Clues Change MS Care, and more...
Published: September 9, 2026
Duration: 11:07
Precision Macrophage Targeting Revolutionizes Fibrosis Therapy Across Multiple Organs
Wyss Institute Secures $12M Contract for Cutting-Edge Fetal Oxygen Monitoring Technology
2.71 Billion Exposed to Second-Hand Smoke Globally in 2023; Women and Children at High Risk
Cortical Involvement in MS: New Insights into Early Pathology and Treatment Strategies
Refined Aortic Surgery Timing: Height-Indexed Metrics and CE-CTA Enhance Risk Assessment
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: BIOENGINEER.ORG
Wyss Institute Secures $12M Contract for Cutting-Edge Fetal Oxygen Monitoring Technology
2.71 Billion Exposed to Second-Hand Smoke Globally in 2023; Women and Children at High Risk
Cortical Involvement in MS: New Insights into Early Pathology and Treatment Strategies
Refined Aortic Surgery Timing: Height-Indexed Metrics and CE-CTA Enhance Risk Assessment
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: BIOENGINEER.ORG